Back
Theravance Biopharma Stock Price Chart
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE
Buy
70
TBPH
Theravance Biopharma
Last Price:
10.04
Seasonality Move:
7.6%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TBPH is experiencing slight buying pressure.
Theravance Biopharma Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.84 | Buy |
| 20-day SMA: | 9.67 | Buy |
| 50-day SMA: | 8.95 | Buy |
| 200-day SMA: | 8.88 | Buy |
| 8-day EMA: | 9.86 | Buy |
| 20-day EMA: | 9.59 | Buy |
| 50-day EMA: | 9.15 | Buy |
| 200-day EMA: | 9.01 | Buy |
Theravance Biopharma Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.29 | Buy |
| Relative Strength Index (14 RSI): | 63.64 | Buy |
| Chaikin Money Flow: | 21611 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.12 - 9.9) | Buy |
| Bollinger Bands (100): | (7.96 - 9.5) | Buy |
Theravance Biopharma Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Theravance Biopharma Stock
Is Theravance Biopharma Stock a Buy?
- Theravance Biopharma share price is 10.04 while TBPH 8-day simple moving average is 9.84, which is a Buy signal.
- The stock price of TBPH is 10.04 while Theravance Biopharma 20-day SMA is 9.67, which makes it a Buy.
- Theravance Biopharma 50-day simple moving average is 8.95 while TBPH share price is 10.04, making it a Buy technically.
- TBPH stock price is 10.04 and Theravance Biopharma 200-day simple moving average is 8.88, creating a Buy signal.
TBPH Technical Analysis vs Fundamental Analysis
Buy
70
Theravance Biopharma (TBPH)
is a Buy
Is Theravance Biopharma a Buy or a Sell?
-
Theravance Biopharma stock is rated a Buy
The current Theravance Biopharma [TBPH] share price is $10.04. The Score for TBPH is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
Theravance Biopharma Stock Info
Market Cap:
493.71M
Price in USD:
10.04
Share Volume:
129.67K
Theravance Biopharma 52-Week Range
52-Week High:
11.71
52-Week Low:
7.44
Buy
70
Theravance Biopharma (TBPH)
is a Buy
Theravance Biopharma Share Price Forecast
-
What is the Theravance Biopharma stock price today?
The Theravance Biopharma stock price is 10.04 USD today. -
Will TBPH stock go up or go down?
Theravance Biopharma> share price is forecast to RISE/FALL based on technical indicators -
Is Theravance Biopharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Theravance Biopharma is not overvalued.
Is Theravance Biopharma Stock a Buy?
- Theravance Biopharma share price is 10.04 while TBPH 8-day exponential moving average is 9.86, which is a Buy signal.
- The stock price of TBPH is 10.04 while Theravance Biopharma 20-day EMA is 9.59, which makes it a Buy.
- Theravance Biopharma 50-day exponential moving average is 9.15 while TBPH share price is 10.04, making it a Buy technically.
- TBPH stock price is 10.04 and Theravance Biopharma 200-day simple moving average is 9.01, creating a Buy signal.
Fundamental Analysis of Theravance Biopharma
Is Theravance Biopharma a good investment?
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.33 per share, and an increase next year of $1.08 per share.
Technical Analysis of Theravance Biopharma
Should I short Theravance Biopharma stock?
- TBPH Moving Average Covergence Divergence (MACD) indicator is 0.29, suggesting Theravance Biopharma is a Buy
- Theravance Biopharma Relative Strength Index (RSI) is 63.64, which suggest Theravance Biopharma is overbought
- The Bollinger Bands (25) for Theravance Biopharma is (9.12 - 9.9), which suggest Theravance Biopharma is a Buy
- The Bollinger Bands (100) for Theravance Biopharma is (7.96 - 9.5), which suggest Theravance Biopharma is a Buy
* Theravance Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.